Evaluation of Study Experiences of Neuroendocrine Tumor Patients
Not yet recruiting
- Conditions
- Neuroendocrine Tumors
- Registration Number
- NCT05967481
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Taking part in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.
This research will admit a wide range of data on the clinical study experience of neuroendocrine tumor patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future patients with neuroendocrine tumor.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Patient is at least 18 years of age
- Diagnosis of neuroendocrine tumor
- Ability to understand and the willingness to sign a written informed consent document
Exclusion Criteria
- Enrolled in another research study
- Patients with psychiatric illness/social situations that would limit compliance with study requirements
- Pregnant or lactating woman
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of neuroendocrine tumor patients who remain in clinical trial until completion 12 months Rate of patients who decide to join in a neuroendocrine tumor clinical research 3 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Power Life Sciences
🇺🇸San Francisco, California, United States